1. Home
  2. LXFR vs CRVS Comparison

LXFR vs CRVS Comparison

Compare LXFR & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXFR
  • CRVS
  • Stock Information
  • Founded
  • LXFR 1898
  • CRVS 2014
  • Country
  • LXFR United States
  • CRVS United States
  • Employees
  • LXFR N/A
  • CRVS N/A
  • Industry
  • LXFR Major Chemicals
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LXFR Industrials
  • CRVS Health Care
  • Exchange
  • LXFR Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • LXFR 314.6M
  • CRVS 305.4M
  • IPO Year
  • LXFR 2012
  • CRVS 2016
  • Fundamental
  • Price
  • LXFR $12.52
  • CRVS $4.18
  • Analyst Decision
  • LXFR
  • CRVS Strong Buy
  • Analyst Count
  • LXFR 0
  • CRVS 4
  • Target Price
  • LXFR N/A
  • CRVS $15.00
  • AVG Volume (30 Days)
  • LXFR 123.0K
  • CRVS 1.2M
  • Earning Date
  • LXFR 07-29-2025
  • CRVS 08-05-2025
  • Dividend Yield
  • LXFR 4.17%
  • CRVS N/A
  • EPS Growth
  • LXFR 49063.50
  • CRVS N/A
  • EPS
  • LXFR 0.79
  • CRVS N/A
  • Revenue
  • LXFR $399,500,000.00
  • CRVS N/A
  • Revenue This Year
  • LXFR $2.63
  • CRVS N/A
  • Revenue Next Year
  • LXFR $3.30
  • CRVS N/A
  • P/E Ratio
  • LXFR $15.87
  • CRVS N/A
  • Revenue Growth
  • LXFR 1.63
  • CRVS N/A
  • 52 Week Low
  • LXFR $9.41
  • CRVS $1.77
  • 52 Week High
  • LXFR $15.64
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • LXFR 62.10
  • CRVS 55.23
  • Support Level
  • LXFR $11.89
  • CRVS $3.79
  • Resistance Level
  • LXFR $12.85
  • CRVS $4.09
  • Average True Range (ATR)
  • LXFR 0.32
  • CRVS 0.29
  • MACD
  • LXFR 0.06
  • CRVS -0.01
  • Stochastic Oscillator
  • LXFR 80.18
  • CRVS 76.27

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: